CN105833748A - 一种高通量血液透析膜及其制备方法 - Google Patents
一种高通量血液透析膜及其制备方法 Download PDFInfo
- Publication number
- CN105833748A CN105833748A CN201610447951.2A CN201610447951A CN105833748A CN 105833748 A CN105833748 A CN 105833748A CN 201610447951 A CN201610447951 A CN 201610447951A CN 105833748 A CN105833748 A CN 105833748A
- Authority
- CN
- China
- Prior art keywords
- parts
- halloysite nanotubes
- high flux
- flux hemodialysis
- modified halloysite
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000001631 haemodialysis Methods 0.000 title claims abstract description 52
- 230000000322 hemodialysis Effects 0.000 title claims abstract description 52
- 238000002360 preparation method Methods 0.000 title claims abstract description 22
- 239000012528 membrane Substances 0.000 title abstract description 25
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims abstract description 60
- HPTYUNKZVDYXLP-UHFFFAOYSA-N aluminum;trihydroxy(trihydroxysilyloxy)silane;hydrate Chemical class O.[Al].[Al].O[Si](O)(O)O[Si](O)(O)O HPTYUNKZVDYXLP-UHFFFAOYSA-N 0.000 claims abstract description 45
- 239000002071 nanotube Substances 0.000 claims abstract description 45
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 36
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 claims abstract description 35
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims abstract description 34
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 claims abstract description 34
- 229920001661 Chitosan Polymers 0.000 claims abstract description 20
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims abstract description 18
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 claims abstract description 18
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 17
- 229920000954 Polyglycolide Polymers 0.000 claims abstract description 17
- 229920000669 heparin Polymers 0.000 claims abstract description 17
- 229960002897 heparin Drugs 0.000 claims abstract description 17
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 claims abstract description 17
- UWJJYHHHVWZFEP-UHFFFAOYSA-N pentane-1,1-diol Chemical compound CCCCC(O)O UWJJYHHHVWZFEP-UHFFFAOYSA-N 0.000 claims abstract description 17
- 229920002239 polyacrylonitrile Polymers 0.000 claims abstract description 17
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 17
- 239000004633 polyglycolic acid Substances 0.000 claims abstract description 17
- 235000010265 sodium sulphite Nutrition 0.000 claims abstract description 17
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims abstract description 8
- 230000004907 flux Effects 0.000 claims description 32
- 238000003756 stirring Methods 0.000 claims description 27
- 125000005233 alkylalcohol group Chemical group 0.000 claims description 23
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 claims description 17
- 235000014121 butter Nutrition 0.000 claims description 17
- 239000000203 mixture Substances 0.000 claims description 11
- 229920002101 Chitin Polymers 0.000 claims description 10
- 238000004108 freeze drying Methods 0.000 claims description 10
- 238000010438 heat treatment Methods 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 230000004048 modification Effects 0.000 claims description 7
- 238000012986 modification Methods 0.000 claims description 7
- 230000001954 sterilising effect Effects 0.000 claims description 7
- 239000011135 tin Substances 0.000 claims description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims description 4
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- 238000001354 calcination Methods 0.000 claims description 3
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 229910052621 halloysite Inorganic materials 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 abstract description 21
- 239000004202 carbamide Substances 0.000 abstract description 11
- 238000000108 ultra-filtration Methods 0.000 abstract description 10
- 206010061218 Inflammation Diseases 0.000 abstract description 9
- 102000015736 beta 2-Microglobulin Human genes 0.000 abstract description 9
- 108010081355 beta 2-Microglobulin Proteins 0.000 abstract description 9
- 230000004054 inflammatory process Effects 0.000 abstract description 9
- 206010067484 Adverse reaction Diseases 0.000 abstract 1
- 102000009027 Albumins Human genes 0.000 abstract 1
- 108010088751 Albumins Proteins 0.000 abstract 1
- 229910021627 Tin(IV) chloride Inorganic materials 0.000 abstract 1
- 230000006838 adverse reaction Effects 0.000 abstract 1
- 230000015271 coagulation Effects 0.000 abstract 1
- 238000005345 coagulation Methods 0.000 abstract 1
- -1 hexamethylene ethanethiol Chemical compound 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 abstract 1
- 230000008359 toxicosis Effects 0.000 abstract 1
- 230000002485 urinary effect Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 37
- 235000013877 carbamide Nutrition 0.000 description 10
- 229940045136 urea Drugs 0.000 description 10
- 230000023555 blood coagulation Effects 0.000 description 9
- 231100000572 poisoning Toxicity 0.000 description 8
- 230000000607 poisoning effect Effects 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 6
- 238000000502 dialysis Methods 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 239000000385 dialysis solution Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 3
- 208000009304 Acute Kidney Injury Diseases 0.000 description 2
- 208000033626 Renal failure acute Diseases 0.000 description 2
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 2
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 201000011040 acute kidney failure Diseases 0.000 description 2
- 208000012998 acute renal failure Diseases 0.000 description 2
- 208000020832 chronic kidney disease Diseases 0.000 description 2
- 208000022831 chronic renal failure syndrome Diseases 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 229940116269 uric acid Drugs 0.000 description 2
- 102100028967 HLA class I histocompatibility antigen, alpha chain G Human genes 0.000 description 1
- 101710197836 HLA class I histocompatibility antigen, alpha chain G Proteins 0.000 description 1
- 102000008100 Human Serum Albumin Human genes 0.000 description 1
- 108091006905 Human Serum Albumin Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920006393 polyether sulfone Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 239000002441 uremic toxin Substances 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
- B01D71/06—Organic material
- B01D71/48—Polyesters
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/14—Ultrafiltration; Microfiltration
- B01D61/145—Ultrafiltration
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D67/00—Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
- B01D67/0002—Organic membrane manufacture
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
- B01D69/02—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor characterised by their properties
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
- B01D71/02—Inorganic material
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
- B01D71/06—Organic material
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
- B01D71/06—Organic material
- B01D71/40—Polymers of unsaturated acids or derivatives thereof, e.g. salts, amides, imides, nitriles, anhydrides, esters
- B01D71/42—Polymers of nitriles, e.g. polyacrylonitrile
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
- B01D71/06—Organic material
- B01D71/74—Natural macromolecular material or derivatives thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Water Supply & Treatment (AREA)
- Inorganic Chemistry (AREA)
- Manufacturing & Machinery (AREA)
- External Artificial Organs (AREA)
- Cosmetics (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610447951.2A CN105833748B (zh) | 2016-06-21 | 2016-06-21 | 一种高通量血液透析膜及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610447951.2A CN105833748B (zh) | 2016-06-21 | 2016-06-21 | 一种高通量血液透析膜及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105833748A true CN105833748A (zh) | 2016-08-10 |
CN105833748B CN105833748B (zh) | 2018-01-19 |
Family
ID=56576870
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610447951.2A Expired - Fee Related CN105833748B (zh) | 2016-06-21 | 2016-06-21 | 一种高通量血液透析膜及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105833748B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106076126A (zh) * | 2016-08-17 | 2016-11-09 | 林春梅 | 一种生物基血液透析膜及其制备方法 |
CN109316986A (zh) * | 2018-11-07 | 2019-02-12 | 中南大学 | 一种丙烯酸和磺化二羟丙基壳聚糖改性聚砜膜及其制备方法 |
CN109647225A (zh) * | 2019-01-22 | 2019-04-19 | 东华大学 | 一种含有定向毒素去除通道的纳米纤维复合血液透析膜及其制备 |
CN111013397A (zh) * | 2019-11-21 | 2020-04-17 | 天津工业大学 | 一种植物多酚-聚丙烯酰吗啉复合改性血液透析膜及其制备方法与应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08318143A (ja) * | 1995-05-24 | 1996-12-03 | Asahi Chem Ind Co Ltd | 再生セルロース製中空糸膜 |
CN104888625A (zh) * | 2015-05-20 | 2015-09-09 | 苏州市贝克生物科技有限公司 | 一种聚丙烯腈血液透析膜及其制备方法 |
CN105597554A (zh) * | 2015-09-30 | 2016-05-25 | 苏州蔻美新材料有限公司 | 一种血液透析膜及其制备方法 |
-
2016
- 2016-06-21 CN CN201610447951.2A patent/CN105833748B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08318143A (ja) * | 1995-05-24 | 1996-12-03 | Asahi Chem Ind Co Ltd | 再生セルロース製中空糸膜 |
CN104888625A (zh) * | 2015-05-20 | 2015-09-09 | 苏州市贝克生物科技有限公司 | 一种聚丙烯腈血液透析膜及其制备方法 |
CN105597554A (zh) * | 2015-09-30 | 2016-05-25 | 苏州蔻美新材料有限公司 | 一种血液透析膜及其制备方法 |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106076126A (zh) * | 2016-08-17 | 2016-11-09 | 林春梅 | 一种生物基血液透析膜及其制备方法 |
CN109316986A (zh) * | 2018-11-07 | 2019-02-12 | 中南大学 | 一种丙烯酸和磺化二羟丙基壳聚糖改性聚砜膜及其制备方法 |
CN109316986B (zh) * | 2018-11-07 | 2021-09-21 | 中南大学 | 一种丙烯酸和磺化二羟丙基壳聚糖改性聚砜膜及其制备方法 |
CN109647225A (zh) * | 2019-01-22 | 2019-04-19 | 东华大学 | 一种含有定向毒素去除通道的纳米纤维复合血液透析膜及其制备 |
CN109647225B (zh) * | 2019-01-22 | 2021-07-20 | 东华大学 | 一种含有定向毒素去除通道的纳米纤维复合血液透析膜及其制备 |
CN111013397A (zh) * | 2019-11-21 | 2020-04-17 | 天津工业大学 | 一种植物多酚-聚丙烯酰吗啉复合改性血液透析膜及其制备方法与应用 |
Also Published As
Publication number | Publication date |
---|---|
CN105833748B (zh) | 2018-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9138529B2 (en) | Anticoagulant-free dialysis systems and methods | |
US11478757B2 (en) | High cut-off hemodialysis membrane for use in liver dialysis | |
Su et al. | Evaluation of polyethersulfone highflux hemodialysis membrane in vitro and in vivo | |
CN105833748A (zh) | 一种高通量血液透析膜及其制备方法 | |
AU2008303785B2 (en) | Hydrophilic membranes with a non-ionic surfactant | |
JP2003299730A (ja) | 蛋白質含有液から蛋白質−結合物質を透析により分離する膜と方法 | |
JP2009540903A (ja) | 医学的な使用のための支持体を処理するための陽イオン性ポリマーのコロイド懸濁液の使用 | |
Locatelli et al. | Removal of small and middle molecules by convective techniques | |
Su et al. | Polyethersulfone hollow fiber membranes for hemodialysis | |
WO2005070478A1 (ja) | 血漿交換廃液浄化循環透析装置 | |
Hoenich et al. | Dialysers | |
JP2012529321A (ja) | 透析装置 | |
Canaud et al. | Online hemodiafiltration: a multipurpose therapy for improving quality of renal replacement therapy | |
Su et al. | Clinical evaluation of polyethersulfone high‐flux hemodialysis membrane compared to other membranes | |
Klinkmann et al. | Clinical relevance of biocompatibility—the material cannot be divorced from the device | |
de Francisco et al. | Hemodiafiltration with on-line endogenous reinfusion | |
Hoenich et al. | Clinical investigation of the role of membrane structure on blood contact and solute transport characteristics of a cellulose membrane | |
Ronco et al. | Membranes for hemodialysis | |
Hoenich | Membranes and filters for haemodiafiltration | |
JP4810720B2 (ja) | 選択除去膜およびそれを用いた血液処理器 | |
JPH11309356A (ja) | ポリスルホン系選択分離膜 | |
Duranti | Importance of Development of Dialysis Membranes for Purification of Small, Middle, High Molecular Weight and Protein-Bound Uremic Toxins: The Asymmetric Cellulose Triacetate (SOLACEA™-H) | |
JP2007144228A (ja) | 血漿交換廃液浄化循環透析方法 | |
Reddy | Design of artificial kidneys | |
Maduell et al. | Comparison of efficacy and safety of the new generation helixone dialyzers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Li Changhong Inventor after: Zhang Guoyan Inventor after: Yu Shuang Inventor after: Zhao Bingbing Inventor after: Bai Yu Inventor before: Lin Chunmei |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20171221 Address after: 154007 No. 148 Xuefu street, Heilongjiang, Jiamusi Applicant after: Jiamusi University Address before: 130000 Chaoyang District, Jilin, liberty Road, No. 19, No. Applicant before: Lin Chunmei |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180119 Termination date: 20190621 |